Virtu Financial LLC Akebia Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

A detailed history of Virtu Financial LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 55,746 shares of AKBA stock, worth $102,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,746
Previous 75,079 25.75%
Holding current value
$102,572
Previous $77,000 3.9%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024
SELL
$0.94 - $1.55 $18,173 - $29,966
-19,333 Reduced 25.75%
55,746 $74,000
Q2 2024

Aug 09, 2024
BUY
$0.86 - $1.63 $64,567 - $122,378
75,079 New
75,079 $77,000
Q4 2023

Feb 26, 2024
BUY
$0.8 - $1.28 $47,583 - $76,133
59,479 New
59,479 $74,000
Q2 2023

Jul 27, 2023
SELL
$0.51 - $1.43 $24,082 - $67,526
-47,221 Reduced 48.26%
50,633 $46,000
Q1 2023

May 01, 2023
BUY
$0.56 - $1.15 $54,798 - $112,532
97,854 New
97,854 $55,000
Q2 2022

Aug 09, 2022
SELL
$0.32 - $0.67 $41,903 - $87,735
-130,949 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$0.72 - $2.93 $94,283 - $383,680
130,949 New
130,949 $94,000
Q3 2021

Nov 12, 2021
SELL
$2.35 - $3.88 $108,734 - $179,527
-46,270 Closed
0 $0
Q2 2021

Sep 17, 2021
SELL
$2.83 - $4.2 $331,851 - $492,500
-117,262 Reduced 71.71%
46,270 $175,000
Q1 2021

May 19, 2021
BUY
$2.92 - $5.06 $477,513 - $827,471
163,532 New
163,532 $554,000
Q4 2020

Feb 24, 2021
SELL
$2.22 - $3.78 $182,712 - $311,105
-82,303 Closed
0 $0
Q3 2020

Dec 11, 2020
BUY
$2.39 - $13.08 $196,704 - $1.08 Million
82,303 New
82,303 $207,000
Q2 2020

Aug 07, 2020
SELL
$6.67 - $13.58 $130,004 - $264,687
-19,491 Closed
0 $0
Q4 2019

Feb 04, 2020
BUY
$3.16 - $6.73 $1,715 - $3,654
543 Added 2.87%
19,491 $123,000
Q3 2019

Nov 20, 2019
BUY
$3.55 - $5.4 $67,265 - $102,319
18,948 New
18,948 $74,000
Q1 2019

Apr 12, 2019
SELL
$5.41 - $8.73 $152,459 - $246,020
-28,181 Closed
0 $0
Q4 2018

Jan 16, 2019
BUY
$5.39 - $9.15 $151,895 - $257,856
28,181 New
28,181 $156,000
Q2 2018

Jul 30, 2018
SELL
$9.15 - $11.34 $92,387 - $114,499
-10,097 Closed
0 $0
Q2 2018

Jul 30, 2018
SELL
$9.15 - $11.34 $121,283 - $150,311
-13,255 Reduced 56.76%
10,097 $101,000
Q1 2018

May 14, 2018
BUY
$9.53 - $15.68 $104,496 - $171,931
10,965 Added 88.52%
23,352 $223,000
Q4 2017

Feb 09, 2018
BUY
$14.24 - $19.59 $28,693 - $39,473
2,015 Added 19.43%
12,387 $184,000
Q3 2017

Nov 15, 2017
BUY
$13.06 - $19.67 $135,458 - $204,017
10,372
10,372 $0

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $338M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email